For the Quarter Ending December 2022
North America
In the fourth quarter of 2022, the Fluconazole market in the North American region showcased an irregular trajectory. It was projected at the start of Q4 2022 that prices would rise in the second month of the quarter due to increasing end-user sector demand and other logistical challenges.
The implementation of zero covid rules hampered trading activity and halted shipments, which benefited the Fluconazole market. The market remained competitive despite higher manufacturing costs brought on by rising energy prices.
However, later in December, as a result of domestic retailers having an adequate supply on hand, fluconazole API prices did decrease. Because of the policies being loosened and the weak downstream demand, the market remained depressed. By the end of Q3 2022, prices were recorded to drop, with values accessed at USD 159020/MT with an average quarterly inclination of 0.99%.
Asia
Fluconazole sales in the Asia Pacific Region had an erratic fourth-quarter trajectory in 2022. It was indicated at the beginning of Q4 2022 that due to rising end-user sector demand and various logistical issues, prices would increase during the second month of the quarter. The adoption of zero covid regulations disrupted shipments and hindered trading activity, which had a favorable impact on the Fluconazole market. Due to increased manufacturing costs driven by rising energy prices, the market remained competitive. Later in December, though, fluconazole API prices did drop because domestic stores had enough inventory on hand. The market remained poor as a result of the relaxing of policies as well as the lackluster downstream demand. Towards the end of Q4, the prices of Salicylic acid were recorded at USD 153200/ton FOB Shanghai (China), with an average quarterly inclination of 0.54%.
Europe
In the third quarter of 2022, Fluconazole API market sentiments in Europe showcased fluctuating behaviour. At the start of Q4 2022 that prices rose till the second month of the quarter as a result of increasing end-user sector demand and other logistical challenges. The implementation of zero covid rules hampered trading activity and halted shipments, which benefited the fluconazole market in the European region. The market remained competitive despite higher manufacturing costs brought on by rising energy prices. However, later in December, because of domestic retailers having an adequate supply on hand, fluconazole API prices did decrease. Also, policies being loosened and the weak downstream demand, the market remained depressed in December. Toward the end of Q4, the values accessed at USD 162020/MT with an average quarterly inclination of 0.67%.
For the Quarter Ending September 2022
North America
In the third quarter of 2022, Fluconazole showcased decelerating price movement in the North American market because of the stabilization in the prices of feed Methanol from the regional market. Throughout the quarter, feed Methanol prices showcased a stable trajectory globally, propelling the prices of Fluconazole to decrease in the regional market. Substantial cost depreciation also affected the price of Flucoazole API. Stable costs for production and regular operational rates ket the market sentiments feeble. By the end of Q3 2022, prices were recorded to drop with values accessed at USD 154450/MT with an average quarterly declination of 0.95%.
Asia
During the third quarter of 2022, the Fluconazole API market witnessed an upward trajectory due to increasing feed prices and fluctuating demand from downstream pharmaceutical industries. With the commencement of Q3 2022, the prices of feed methanol hiked up, affecting the prices of Fluconazole in the domestic market in the Chinese provinces. Additionally, the production halts and lower operational costs prompted by adverse weather conditions further acted the prices to soar continuously. Also, the increased energy price and energy crisis assisted in the hiked-up trajectory of Fluconazole API. Toward the end of Q3, the values accessed at USD 150850/MT with an average quarterly inclination of 1.78%.
Europe
In the third quarter of 2022, Fluconazole API market sentiments in Europe remained tormented. The Fluconazole API trade market decelerated in the European region throughout the quarter due to stable prices of feed methanol globally, sufficient supply, and bearish demand from end-user industries. To cope with the rising inflation, the government rose the interest rates to bring down the consumer's request, eventually forcing the domestic merchants to quote lower values. Also, enough inventories and a stable supply chain kept the market sentiments feeble. Toward the end of Q3, the values accessed at USD 158890/MT with an average quarterly declination of 3.33%.
For the Quarter Ending June 2022
North America
In the second quarter of 2022, Fluconazole API market sentiments in North America remained mixed. The Fluconazole API trade market decelerated in North America during the first half of Q2 2022 due to stable prices of feed methanol globally, sufficient supply, and bearish demand from end-user industries. Prices rose marginally at the onset second half of Q2 owing to the tightness of natural gas in the USA's market and high energy demand. The increase in supplies and weak trading activities contributed to the downward trend. Also, with low manufacturing costs and sluggish demand, cost-cutting was experienced by the Fluconazole market. Toward the end of Q2, the values accessed at USD 158950/MT with a quarterly declination of 1.17%.
Asia
During the second quarter of 2022, the Fluconazole API market witnessed an upward trajectory due to increasing feed prices and fluctuating demand from downstream pharmaceutical industries. With the commencement of Q2 2022, the prices of feed methanol were hiked, affecting the prices of Fluconazole to increase in the domestic market. Towards the termination of the first half of Q2 2022, feed methanol prices slumped, prompting the decrease of Fluconazole prices in the Asian Pacific region. Also, the demand from downstream end-user industries went stable. Toward the end of Q2, the values accessed at USD 143140/MT with a quarterly inclination of 3.43%%.
Europe
In the second quarter of 2022, Fluconazole showcased an oscillating price movement in the European market because of the increased prices of feed Methanol from the regional market. At the outset of Q2 2022, feed Methanol prices showcased a stable trajectory globally, propelling the prices of Fluconazole to decrease in the regional market. Substantial cost inflation in drug prices boosted the API market in the second half of Q2 2022. At the termination of Frist half of Q2 2022, Fluconazole prices witnessed a stable increase owing to increased feedstock methanol cost and surging inquiries from the pharmaceutical sector. By Q2 2022, prices were recorded to drop with values accessed at USD 176000/MT with a quarterly declination of 0.53%.
